{"corpus_id":220307145,"paper_sha":"a60fca7b18a7bad65732ce007e55f70c12b979e9","doi":"10.1159/000508991","arxiv_id":null,"pmid":32610334,"pmcid":"7445369","mag_id":3040645987,"dblp_id":null,"acl_id":null,"title":"COVID-19 Infection and Neurological Complications: Present Findings and Future Predictions","year":2020,"publication_date":"2020-07-01","venue":"Neuroepidemiology","journal":{"name":"Neuroepidemiology","pages":"1 - 6","volume":null},"journal_issn":null,"journal_title":null,"publication_types":["Review","JournalArticle"],"pubmed_pub_types":["Journal Article","Review"],"s2_fields_of_study":["Medicine"],"reference_count":49,"citation_count":61,"influential_citation_count":0,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Betacoronavirus","mj":true,"ui":"D000073640"},{"d":"COVID-19","mj":false,"ui":"D000086382"},{"d":"Coronavirus Infections","mj":false,"qs":[{"q":"complications","mj":true,"ui":"Q000150"},{"q":"diagnosis","mj":true,"ui":"Q000175"},{"q":"transmission","mj":false,"ui":"Q000635"}],"ui":"D018352"},{"d":"Forecasting","mj":false,"ui":"D005544"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Nervous System Diseases","mj":false,"qs":[{"q":"diagnosis","mj":true,"ui":"Q000175"},{"q":"etiology","mj":true,"ui":"Q000209"}],"ui":"D009422"},{"d":"Pandemics","mj":false,"ui":"D058873"},{"d":"Pneumonia, Viral","mj":false,"qs":[{"q":"complications","mj":true,"ui":"Q000150"},{"q":"diagnosis","mj":true,"ui":"Q000175"},{"q":"transmission","mj":false,"ui":"Q000635"}],"ui":"D011024"},{"d":"SARS-CoV-2","mj":false,"ui":"D000086402"}],"chemicals":null,"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"https://karger.com/ned/article-pdf/54/5/364/3157832/000508991.pdf","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/a60fca7b18a7bad65732ce007e55f70c12b979e9","s2_open_access_license":"other-oa","s2_open_access_status":"HYBRID","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"The present outbreak caused by SARS-CoV-2, an influenza virus with neurotropic potential, presents with neurological manifestations in a large proportion of the affected individuals. Disorders of the central and peripheral nervous system are all present, while stroke, ataxia, seizures, and depressed level of consciousness are more common in severely affected patients. People with these severe complications are most likely elderly with medical comorbidities, especially hypertension and other vascular risk factors. However, postinfectious complications are also expected. Neurological disorders as sequelae of influenza viruses have been repeatedly documented in the past and include symptoms, signs, and diseases occurring during the acute phase and, not rarely, during follow-up. Postinfectious neurological complications are the result of the activation of immune mechanisms and can explain the insurgence of immune-mediated diseases, including the Guillain-Barré syndrome and other diseases of the central and peripheral nervous system that in the past occurred as complications of viral infections and occasionally with vaccines. For these reasons, the present outbreak calls for the introduction of surveillance systems to monitor changes in the frequency of several immune-mediated neurological diseases. These changes will determine a reorganization of the measures apt to describe the interaction between the virus, the environment, and the host in areas of different dimensions, from local communities to regions with several millions of inhabitants. The public health system, mainly primary care, needs to be strengthened to ensure that research and development efforts are directed toward right needs and directions. To cope with the present pandemic, better collaboration is required between international organizations along with more research funding, and tools in order to detect, treat, and prevent future epidemics.","claims":[{"public_id":"cl_bcbeccb183d37be1a966489844357e7e","status":"active","text":"Elderly patients with hypertension and other vascular risk factors are most likely to develop severe neurological complications.","confidence":0.88,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_bcbeccb183d37be1a966489844357e7e"},{"public_id":"cl_4654f983ee4958ba66a2dd8033a69009","status":"active","text":"Neurological manifestations occur in a large proportion of SARS-CoV-2 infections, with central and peripheral nervous system disorders observed.","confidence":0.93,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_4654f983ee4958ba66a2dd8033a69009"},{"public_id":"cl_b762afe34422492b411e4280d6522a12","status":"active","text":"Postinfectious neurological complications are expected and are attributed to immune mechanism activation, including Guillain-Barré syndrome and other immune-mediated diseases of the nervous system.","confidence":0.92,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_b762afe34422492b411e4280d6522a12"},{"public_id":"cl_c9ec8e9af574ac0275be170157a989e7","status":"active","text":"Stroke, ataxia, seizures, and depressed level of consciousness are more common among severely affected patients.","confidence":0.9,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_c9ec8e9af574ac0275be170157a989e7"},{"public_id":"cl_f7d30b63399a12fd1b6f88f19712d44c","status":"active","text":"Surveillance systems are needed to monitor changes in the frequency of immune-mediated neurological diseases.","confidence":0.89,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_f7d30b63399a12fd1b6f88f19712d44c"}],"concepts":[{"public_id":"co_01d05ca3b8adc797eec6eeafe6b9cc59","status":"active","name":"ataxia","description":"Impaired coordination of voluntary movements.","types":["symptom","condition"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_01d05ca3b8adc797eec6eeafe6b9cc59"},{"public_id":"co_063e62b19b8a9b0ca81d3ebc815f35ef","status":"active","name":"SARS-CoV-2","description":"The coronavirus associated with the COVID-19 outbreak discussed in the abstract.","types":["virus"],"aliases":["COVID-19 virus"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_063e62b19b8a9b0ca81d3ebc815f35ef"},{"public_id":"co_111073cd01c4232e6063a91d05d93655","status":"active","name":"elderly patients","description":"Older adults identified as being at higher risk for severe complications.","types":["patient group"],"aliases":["older patients"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_111073cd01c4232e6063a91d05d93655"},{"public_id":"co_34c9eb7a014a255c9e15f50ce8669aa2","status":"active","name":"central and peripheral nervous system disorders","description":"Disorders affecting both the brain/spinal cord and the peripheral nerves.","types":["condition"],"aliases":["CNS and PNS disorders"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_34c9eb7a014a255c9e15f50ce8669aa2"},{"public_id":"co_37205eaf487a6215a7a9e373c49795fa","status":"active","name":"neurological manifestations","description":"Clinical signs and symptoms involving the nervous system in infected individuals.","types":["clinical manifestation"],"aliases":["neurological complications"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_37205eaf487a6215a7a9e373c49795fa"},{"public_id":"co_4f9aca8defb8320cfbf45d2efe5492d8","status":"active","name":"hypertension","description":"A medical condition characterized by elevated arterial blood pressure.","types":["risk factor","condition"],"aliases":["high blood pressure"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_4f9aca8defb8320cfbf45d2efe5492d8"},{"public_id":"co_5a8dc0b68b554306cd667d5ce938b3c6","status":"active","name":"immune mechanisms","description":"Host immune processes implicated in the development of postinfectious disease.","types":["mechanism"],"aliases":["immune activation"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_5a8dc0b68b554306cd667d5ce938b3c6"},{"public_id":"co_6c3c39bfe4f261b1456f1280ad3b5ab3","status":"active","name":"surveillance systems","description":"Monitoring systems used to track disease frequency and changes over time.","types":["public health system"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_6c3c39bfe4f261b1456f1280ad3b5ab3"},{"public_id":"co_7f5bbc78288c1576c16631a7fc930d54","status":"active","name":"depressed level of consciousness","description":"Reduced alertness or responsiveness.","types":["symptom"],"aliases":["altered consciousness"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_7f5bbc78288c1576c16631a7fc930d54"},{"public_id":"co_8acf32604393f8f99f4b49afc449bc91","status":"active","name":"stroke","description":"A cerebrovascular event causing acute neurological deficit.","types":["condition"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_8acf32604393f8f99f4b49afc449bc91"},{"public_id":"co_8d8b19da8c872eb301c803bcbb90ada3","status":"active","name":"Guillain-Barré syndrome","description":"An acute immune-mediated neuropathy affecting the peripheral nervous system.","types":["disease"],"aliases":["GBS"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_8d8b19da8c872eb301c803bcbb90ada3"},{"public_id":"co_9e2c41655c3a8625baaa5f6bf5bd2827","status":"active","name":"seizures","description":"Episodes of abnormal, excessive neuronal activity causing transient clinical events.","types":["symptom","condition"],"aliases":["convulsions"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_9e2c41655c3a8625baaa5f6bf5bd2827"},{"public_id":"co_b4f1b27bcbaa06b71753b882b1f3871a","status":"active","name":"postinfectious neurological complications","description":"Neurological disorders that arise after an infection has occurred.","types":["condition"],"aliases":["post-infectious complications"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_b4f1b27bcbaa06b71753b882b1f3871a"},{"public_id":"co_ccafe342bf1edaaf3eeaef13a37e829f","status":"active","name":"immune-mediated neurological diseases","description":"Neurological disorders driven by immune system dysfunction or autoimmunity.","types":["disease category"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_ccafe342bf1edaaf3eeaef13a37e829f"},{"public_id":"co_ccddca85aa36d898e0ac0445113cc2b2","status":"active","name":"vascular risk factors","description":"Clinical factors that increase the likelihood of vascular disease.","types":["risk factor"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_ccddca85aa36d898e0ac0445113cc2b2"}],"external_ids":{"DOI":"10.1159/000508991","ArXiv":null,"PubMed":32610334,"PubMedCentral":"7445369","MAG":3040645987,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://karger.com/ned/article-pdf/54/5/364/3157832/000508991.pdf","landing_url":"https://www.semanticscholar.org/paper/a60fca7b18a7bad65732ce007e55f70c12b979e9","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"other-oa","status":"HYBRID","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":636391,"paper_uid":"1f252638-fe6b-4fa3-86fe-aa71e7c0c717","canonical_identity":{"paper_id":636391,"paper_uid":"1f252638-fe6b-4fa3-86fe-aa71e7c0c717","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/220307145"}